Medicine and Dentistry
Breast Cancer
100%
Hormone Therapy
93%
CDK4/6 Inhibitor
75%
Estrogen Receptor Positive Breast Cancer
63%
Protein Kinase B
34%
Metastatic Breast Cancer
34%
Estrogen Receptor
33%
Fulvestrant
28%
Upregulation
26%
Organoid
23%
Metastatic Carcinoma
22%
Cancer Cell
21%
Mesenchymal-Epithelial Transition
19%
Circulating Tumor Cell
19%
Tamoxifen
17%
Disease Exacerbation
16%
Breast Tumor
14%
Neoplasm
13%
Cancer Biomarkers
13%
Aurora A Kinase
13%
Triple Negative Breast Cancer
13%
Bcl-xL
13%
PI3K/AKT/mTOR Pathway
13%
Minichromosome Maintenance Protein 3
13%
Predictive Marker
13%
Circulating Tumor DNA
13%
Gastrin Releasing Peptide Receptor
13%
Tetraxetan
13%
Lutetium 177
13%
Genetic Transfection
13%
Tumour Heterogeneity
13%
Biological Marker
11%
Tumor
10%
Combination Therapy
8%
Small Interfering RNA
8%
Drug Resistance
7%
B Cell
6%
Primary Tumor
6%
Diseases
6%
Protein P53
5%
Mammalian Target of Rapamycin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
81%
Breast Cancer
78%
Estrogen Receptor Positive Breast Cancer
68%
Fulvestrant
59%
Estrogen Receptor
45%
Metastatic Breast Cancer
41%
Biological Marker
32%
Protein Kinase B
26%
Tamoxifen
17%
Aromatase Inhibitor
15%
Aromatase
13%
Minichromosome Maintenance Protein 3
13%
Triple Negative Breast Cancer
13%
Aurora A Kinase
13%
Cycline
12%
Neoplasm
11%
Disease Exacerbation
10%
Progression Free Survival
10%
Small Interfering RNA
10%
Monotherapy
7%
Protein P53
6%
Epithelial Cell Adhesion Molecule
5%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
43%
Fulvestrant
40%
Upregulation
28%
Cancer Cell
20%
Drug Resistance
17%
SNAI2
17%
Genomics
15%
Gene Expression
14%
Regulatory Network
13%
MicroRNA
13%
Minichromosome Maintenance
13%
Cyclin-Dependent Kinase
13%
Circulating Tumor DNA
13%
Dynamics
13%
Transfection
13%
Protein Kinase B
13%
Genetics
13%
Drug Response
13%
Cell Cycle
6%
JNK Signaling
5%
Progression Free Survival
5%
